Economic TimesLean R·
Why is Liquidia stock plunging? Yutrepia patent case explained
Liquidia shares plunged nearly 50% after a US court ruled against the company in a patent dispute with United Therapeutics, raising concerns over Yutrepia’s commercial prospects.
Read at Economic Times →


